Moomoo AI 已提取核心信息
Avenue Therapeutics, Inc. has officially increased its authorized shares from 75 million to 200 million, as detailed in a recent Form 8-K filing with the SEC. The stockholder consent for this increase was obtained on January 9, 2024, and the Certificate of Amendment was filed with the Delaware Secretary of State on February 20, 2024. This amendment to the company's Third Amended and Restated Certificate of Incorporation is documented in exhibit 3.1 of the report. The company's common stock is traded under the symbol ATXI on the Nasdaq Capital Market.
Avenue Therapeutics, Inc. has officially increased its authorized shares from 75 million to 200 million, as detailed in a recent Form 8-K filing with the SEC. The stockholder consent for this increase was obtained on January 9, 2024, and the Certificate of Amendment was filed with the Delaware Secretary of State on February 20, 2024. This amendment to the company's Third Amended and Restated Certificate of Incorporation is documented in exhibit 3.1 of the report. The company's common stock is traded under the symbol ATXI on the Nasdaq Capital Market.
正如最近向美国证券交易委员会提交的8-K表中所详述的那样，Avenue Therapeutics, Inc.已正式将其授权股票从7500万股增加到2亿股。此次增持的股东同意于2024年1月9日获得，修正证书已于2024年2月20日提交给特拉华州国务卿。对公司第三次修订和重述的公司注册证书的修正案记录在报告的附录3.1中。该公司的普通股在纳斯达克资本市场上交易代码为ATXI。
正如最近向美国证券交易委员会提交的8-K表中所详述的那样，Avenue Therapeutics, Inc.已正式将其授权股票从7500万股增加到2亿股。此次增持的股东同意于2024年1月9日获得，修正证书已于2024年2月20日提交给特拉华州国务卿。对公司第三次修订和重述的公司注册证书的修正案记录在报告的附录3.1中。该公司的普通股在纳斯达克资本市场上交易代码为ATXI。
有用
没用